Filter Results:
(274)
Show Results For
- All HBS Web
(388)
- News (70)
- Research (274)
- Events (7)
- Multimedia (1)
- Faculty Publications (135)
Show Results For
- All HBS Web
(388)
- News (70)
- Research (274)
- Events (7)
- Multimedia (1)
- Faculty Publications (135)
Sort by
- 03 Nov 2015
- First Look
November 3, 2015
at facilitating communication and collaboration between practitioners and academics by introducing key vocabulary and concepts used in rigorous impact evaluation methods, starting with randomized controlled... View Details
Keywords: Sean Silverthorne
- 21 Jul 2006
- Op-Ed
Enron Jury Sent the Right Message
The most noteworthy message of the Enron trial is that corporate executives can be convicted in a court of law for a pattern of deception that may or may not be illegal. Left unaddressed in the trial were... View Details
Keywords: by Malcolm S. Salter
- 05 Feb 2013
- First Look
First Look: Feb. 5
similar to that of advertising. A major challenge is that privacy laws prevent us from observing information about the applicant pool. I overcome this challenge by using order statistic distribution to infer applicant quality from information on enrolled students.... View Details
Keywords: Sean Silverthorne
- 02 Jun 2011
- Research & Ideas
Signing at the Top: The Key to Preventing Tax Fraud?
end of the tax form, after the form has been filled out and, consequently, after the potential cheating has occurred. (It's analogous to a witness first testifying in a court trial and then swearing on a Bible, "For the last twenty... View Details
- 30 Dec 2013
- Research & Ideas
Most Popular Articles of 2013
alleviate congestion, and can actually increase it. Research by Jillian Berry Jaeker, Anita L. Tucker, and Michael H. Lee. Applying Random Coefficient Models to Strategy Research: Testing For Firm Heterogeneity, Predicting Firm-Specific... View Details
Keywords: by Staff
- June 2023 (Revised July 2024)
- Case
Biogen and the Aduhelm Melee
By: Amitabh Chandra and Lauren Gunasti
Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.
This... View Details
This... View Details
Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry
Chandra, Amitabh, and Lauren Gunasti. "Biogen and the Aduhelm Melee." Harvard Business School Case 623-046, June 2023. (Revised July 2024.)
- 20 Aug 2007
- Research & Ideas
HBS Cases: Using Investor Relations Proactively
How should a company deliver financial news—both good and bad—to a broad spectrum of stakeholders, including investors, customers, government, and environmentalists? Energy giants Total and BP have learned best practices through trial and... View Details
- 21 Aug 2012
- Research & Ideas
How to Sink a Startup
Tim Westergren of Pandora and Evan Williams of Twitter. YouTube cofounder and former CEO Chad Hurley has called the book "an invaluable alternative to real-world trial and error." A past recipient of the HBS student-voted award for... View Details
Keywords: by Garry Emmons
- 21 Feb 2017
- First Look
First Look at New Research: February 21
internal beneficiary that made connectedness salient yielded a persistent increase in productivity relative to a control group. We validate this effect in the laboratory and provide evidence that the effect is mediated by an enhanced... View Details
Keywords: Carmen Nobel
- 30 Jan 2012
- Research & Ideas
Measuring the Efficacy of the World’s Managers
larger number of organizations. The researchers have also started to work on management experiments, modeled on the randomized control trials adopted in the medical field. This... View Details
Keywords: by Carmen Nobel
- 10 Nov 2015
- First Look
November 10, 2015
communication and collaboration between practitioners and academics by introducing key vocabulary and concepts used in rigorous impact evaluation methods, starting with randomized controlled View Details
Keywords: Sean Silverthorne
- 02 Nov 2010
- First Look
First Look: November 2, 2010
perceived agreeableness; the decrease in leadership effectiveness perception between moderate and high decision latitude was explained by a decrease in perceived conscientiousness. Theoretical and practical implications of these findings are discussed. Keeping the... View Details
Keywords: Sean Silverthorne
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Microfinance in particular has often been argued, but not without controversy, to be a tool for empowering women. Here, using a randomized controlled trial, we examine whether access to, and marketing of, an... View Details
Keywords: Martha Lagace
- 22 Apr 2014
- First Look
First Look: April 22
Nava, Diego Aycinena, Claudia Martínez A., and Dean Yang Abstract—While remittance flows to developing countries are very large, it is unknown whether migrants desire more control over how remittances are used. This research uses a View Details
Keywords: Sean Silverthorne
- 09 Feb 2010
- First Look
First Look: Feb. 9
both proprietary and shared platforms toward hybrid governance models characterized by centralized control over platform technology (i.e., closed sponsorship) and shared responsibility for serving users (i.e., an open provider role).... View Details
Keywords: Martha Lagace
- 10 Mar 2014
- Research & Ideas
Counting Up the Effects of Sarbanes-Oxley
approach when considering SOX," explains Srinivasan. The most worrisome part of the act on the business side was the mandate that required public companies to obtain an independent audit of their internal control practices. The cost... View Details
- 14 May 2013
- First Look
First Look: May 14
flexible random coefficients aggregate discrete choice model that accommodates heterogeneity in preferences for school quality and athletic success, and an extensive set of school fixed effects to control... View Details
Keywords: Sean Silverthorne
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- 02 Jan 2019
- What Do You Think?
SUMMING UP: Do We Need an Artificial Intelligence Czar?
such a person might be needed. Does the United States need an artificial intelligence czar? What do you think? References: David Ignatius, China’s application of AI should be a Sputnik moment for the U.S. But will it be?, The Washington Post, November 6, 2018. Steven... View Details